Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 5/20 | 0.63 |
| ▸ | IDUA | P35475 | 1/20 | 0.47 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.45 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | PYGB | P11216 | 7/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9112754 | 1.00 | LGALS3 (0.63) | LGALS3IDUALGALS1LGALS9LGALS8 | |
| SCHEMBL5961308 | 1.00 | LGALS3 (0.63) | LGALS3IDUALGALS1LGALS9LGALS8 | |
| SCHEMBL8329271 | 1.00 | LGALS3 (0.63) | LGALS3IDUALGALS1LGALS9LGALS8 | |
| SCHEMBL8327423 | 1.00 | LGALS3 (0.63) | LGALS3IDUALGALS1LGALS9LGALS8 | |
| SCHEMBL1065038 | 1.00 | LGALS3 (0.63) | LGALS3IDUALGALS1LGALS9LGALS8 | |
| SCHEMBL6281121 | 1.00 | LGALS3 (0.63) | LGALS3IDUALGALS1LGALS9LGALS8 | |
| SCHEMBL2688569 | 1.00 | LGALS3 (0.63) | LGALS3IDUALGALS1LGALS9LGALS8 | |
| SCHEMBL2688005 | 0.98 | LGALS3 (0.60) | LGALS3IDUALGALS1LGALS9LGALS8 | |
| SCHEMBL8331451 | 0.98 | LGALS3 (0.60) | LGALS3IDUALGALS1LGALS9LGALS8 | |
| SCHEMBL6785168 | 0.98 | LGALS3 (0.60) | LGALS3IDUALGALS1LGALS9LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1246866-A | Monocyclic compound with four bifunctional groups and NK-2 antagonistic effect | MENARINI RICERCHE SPA (IT) | 2000-03-08 | — | — | CN | claimed |
| CN-117420245-A | Detection method of human dry blood spot ceramide and kit for detecting ceramide | 南京品生医学检验实验室有限公司 | 2024-01-19 | — | — | CN | disclosed |
| US-7312194-B2 | Delivery systems | ALCHEMIA PTY. LTD. (AU) | 2007-12-25 | — | — | US | disclosed |
| EP-1509254-A1 | NEW AGENTS FOR MAGNETIC IMAGING METHOD | Bracco Imaging S.p.A. (IT) | 2005-03-02 | — | — | EP | disclosed |
| US-20040176281-A1 | Delivery systems | ALCHEMIA LIMITED (AU) | 2004-09-09 | — | — | US | disclosed |
| WO-2003103722-A1 | NEW AGENTS FOR MAGNETIC IMAGING METHOD | BRACCO IMAGING S.P.A. (IT) | 2003-12-18 | — | — | WO | disclosed |
| WO-2002053572-A1 | DELIVERY SYSTEMS | ALCHEMIA PTY LTD (AU) | 2002-07-11 | — | — | WO | disclosed |
| US-5872111-A | TOILET BAR SOAP, FACIAL BODY CLEANSER, SHAMPOO, CONDITIONER, COSMETIC,SHAVING CREAM OR LOTION, SHOWER GEL, FABRIC SOFTENING CONDITIONER, AND UNDERARM DEODORANT/ANTI-PERSPIRANT | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1999-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176281-A1 | Delivery systems | MTX2, SGMS2, SGMS1 | LGALS3 965/4885IDUA 358/4885LGALS1 814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.